Prosonix teams with ICL to assess MCPs for COPD and asthma – In-PharmaTechnologist.com


In-PharmaTechnologist.com

Prosonix teams with ICL to assess MCPs for COPD and asthma
In-PharmaTechnologist.com
Prosonix aims to develop new treatments for respiratory diseases though an R&D accord formed with Imperial College London (ICL).

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.